利益冲突下干细胞治疗的伦理原则思考

Thinking on Ethical Principles for Stem Cell Therapy under Conflict of Interests

干细胞技术具有非常可观的医学应用前景,但同时也存在很多伦理问题。尤其是在干细胞的临床治疗中,除了技术本身的伦理问题,卫生系统内部各方的利益冲突、医患之间的利益冲突以及研究者、投资者与医疗机构及患方之间的利益冲突等问题更加值得关注。为了促进干细胞治疗技术沿着正确的方向发展,必须尽快规范干细胞治疗技术的临床试验研究,建立健全准入制度和管理及评估机制,严格遵循干细胞治疗的伦理原则,即严格准入原则、不伤害原则、知情同意原则、非商业化原则.

Stem cell technology has considerable medical prospects, along with many ethical issues. Especially in the clinical treatment of stem cells, in addition to the ethical problems of the technology itself, the multi - party conflicts of interest within the health system between doctors and patients, between researchers, investors and medi- cal institutions and the patients, are increasingly worthy of attention. In order to promote th nology in the right direction, we should regulate clinical trial study of stem cell therapy as e stem cell therapy tech- soon as possible, estab- lish and perfect the access system and management and evaluation mechanism, strictly follow the stem cell therapy ethical principles, strict access principle, no harm principle, the principle of informed consent and the non - com- mercial principle.